Stay updated with breaking news from Sabine richter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Illustration by Elizabeth Brockway/The Daily BeastThe kit arrives in your mailbox in a cardboard box stamped with a modern, serif-font logo. It’s the kind of sleek, clean design so often associated with direct-to-consumer brands that fill your social media feeds with ads. A hip makeup line could easily be inside, or a set of razors with a cutesy name.Instead, you open the box and find a pair of gloves, a specimen collection jar, and an organic cotton tampon.NextGen Jane, a health tech startup fo ....
Close-fought German election goes down to the wire irishtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from irishtimes.com Daily Mail and Mail on Sunday newspapers.
PRA expands COVID-19 pharmacovigilance resources The CRO is offering an expanded range of post-authorization solutions designed to help developers with treatments and vaccines in their product pipeline PRA Health Sciences has expanded its pharmacovigilance solutions to include a broader range of post-marketing services geared toward authorized vaccines and therapeutics for COVID-19. The offerings are designed to enable drug developers to keep up with the speed, accuracy and transparency demands of pharmacovigilance and safety data monitoring associated with COVID-19 treatments and vaccines. Sabine Richter, vice president of pharmacovigilance and patient safety with PRA, said, “As more COVID-19 vaccines and therapeutics are approved, marketing authorization holders will have massive volumes of safety data to review and report in almost real-time. Our pharmacovigilance solutions enable clients to adhere to regulatory reporting and compliance ....
PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics PRA offers post-authorization safety solutions to keep up with the speed of COVID-19 vaccine and therapeutic pharmacovigilance requirements RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including post-authorization safety studies (PASS) delivered by Real World Solutions. With more than 25 years of experience executing comprehensive pharmacovigilance and patient safety services in all key therapeutic areas including infectious diseases, PRA can work closely with drug developers and manufacturers in ensuring long-term safety and efficacy of COVID-19 vaccines and treatments. ....